|
NAPG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.75510000000245E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.173000E-04 |
| Normal-vs-Stage2 |
1.196920E-03 |
| Normal-vs-Stage3 |
1.601240E-04 |
| Normal-vs-Stage4 |
2.30229999998999E-05 |
| Stage1-vs-Stage2 |
3.868400E-01 |
| Stage1-vs-Stage3 |
3.204400E-01 |
| Stage1-vs-Stage4 |
9.319600E-02 |
| Stage2-vs-Stage3 |
9.083600E-01 |
| Stage2-vs-Stage4 |
5.675600E-01 |
| Stage3-vs-Stage4 |
4.232000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.10800000002942E-06 |
| Normal-vs-AfricanAmerican |
4.150400E-02 |
| Normal-vs-Asian |
9.075600E-02 |
| Caucasian-vs-AfricanAmerican |
3.637200E-01 |
| Caucasian-vs-Asian |
4.067600E-02 |
| AfricanAmerican-vs-Asian |
5.997600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.96820000028819E-07 |
| Normal-vs-Female |
3.391800E-04 |
| Male-vs-Female |
4.076000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.580100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.56430999999069E-05 |
| Normal-vs-Age(61-80Yrs) |
5.90649999999693E-05 |
| Normal-vs-Age(81-100Yrs) |
1.703800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.151800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.031400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.861800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.894000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.121600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.139000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.985400E-01 |
| Classical-VS-Follicular |
1.172170E-01 |
| Classical-VS-Other |
6.984200E-02 |
| Classical-VS-Normal |
3.809600E-04 |
| Tall-VS-Follicular |
3.619200E-01 |
| Tall-VS-Other |
9.822400E-02 |
| Tall-VS-Normal |
2.274300E-02 |
| Follicular-VS-Other |
3.277200E-01 |
| Follicular-VS-Normal |
2.179700E-04 |
| Other-VS-Normal |
2.604300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.86080000003286E-06 |
| Normal-vs-N1 |
7.205700E-04 |
| N0-vs-N1 |
7.314200E-01 |
|
|
